Effect of amezinium on the release and catabolism of 3H-monoamines in brain slices.
D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D011427:Propiophenones / Q000494:pharmacology; D011724:Pyridazines / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013566:Sympathomimetics / Q000494:pharmacology*; D014191:Tranylcypromine / Q000494:pharmacology
D001679:Biogenic Amines; D011427:Propiophenones; D011724:Pyridazines; D013566:Sympathomimetics; D014191:Tranylcypromine; C006104:U 0521; D010293:Pargyline; C027784:amezinium; D009638:Norepinephrine